Low-dose maintenance therapy with infliximab prevents postsurgical recurrence of Crohn's disease.
Fraser
Gerald M
GM
D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D003424:Crohn Disease / Q000517:prevention & control* / Q000601:surgery*; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage*; D000069285:Infliximab; D055502:Secondary Prevention
D000911:Antibodies, Monoclonal; D007155:Immunologic Factors; D000069285:Infliximab